Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

• Manish A. Shah,
• Zev A. Wainberg,
• Daniel V. T. Catenacci,
• Howard S. Hochster,
• James Ford,
• Pamela Kunz,
• Fa-Chyi Lee,
• Howard Kallender,
• Fabiola Cecchi,
• Daniel C. Rabe,
• Harold Keer,
• Anne-Marie Martin,
• Yuan Liu,
• Robert Gagnon,
• Peter Bonate,
• Li Liu,
• Tona Gilmer,
•  [ ... ],
• Donald P. Bottaro
• [ view all ]
• [ view less ]